Rx Technologies Corp.

CIK:0001453086|SEC Filings

STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended		46 Months Ended
STATEMENTS OF OPERATIONS (USD $)	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
STATEMENTS OF OPERATIONS [Abstract]
Net sales
Cost of Sales
Gross Profit
Expenses:
General & Administrative	2,750	1,800	3,750	5,650	21,575
Legal and Accounting	3,500	2,000	7,500	7,250	43,125
Fees to Directors					25,000
Consulting, Marketing and Advertising	2,500		16,700	15,000	93,700
Amortization and Impairments	15,000		15,000	1,834	63,222
Total Expenses	23,750	3,800	42,950	29,734	246,622
Net (loss) before Income Taxes	(23,750)	(3,800)	(42,950)	(29,734)	(246,622)
Provision for Income Taxes
Net (loss)	$ (23,750)	$ (3,800)	$ (42,950)	$ (29,734)	$ (246,622)
Basic and diluted net loss per common share	$ 0.0	$ 0.0	$ 0.0	$ 0.0
Weighted average number of common shares outstanding	94,441,850	66,121,850	85,754,964	63,262,359

CONDENSED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended		46 Months Ended
CONDENSED STATEMENTS OF CASH FLOWS (USD $)	Sep. 30, 2012	Sep. 30, 2011	Sep. 30, 2012
OPERATING ACTIVITIES:
Net loss	$ (42,950)	$ (29,734)	$ (246,622)
Adjustments to reconcile net loss to net cash used in operating activities:
Increase in amortization and impairment	15,000	1,834	63,222
Stock issued for services	16,700	26,500	128,200
Changes in operating assets and liabilities:
Acquisition of intellectual property			(6,000)
Increase/(Decrease) in accounts payable and accrued expenses	2,250	(1,900)	9,500
Net cash (used in) provided by operating activities	(9,000)	(3,300)	(51,700)
FINANCING ACTIVITIES:
Increase/(decrease) in due to related parties	9,000	3,300	32,700
Increase in notes payable
Proceeds from issuance of common stock			19,000
Net cash provided by (used in) financing activities	9,000	3,300	51,700
NET INCREASE (DECREASE) IN CASH
CASH BEGINNING BALANCE
CASH ENDING BALANCE
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Taxes paid
Interest paid
NON-CASH TRANSACTIONS AFFECTING OPERATING, INVESTING AND FINANCING ACTIVITIES:
Issuance of common stock for related party advances	11,700	16,500	28,200
Issuance of common stock for acquisition of intellectual property			62,222
Issuance of notes payable for acquisition of intellectual property			$ 18,000

BALANCE SHEETS (USD $)	Sep. 30, 2012	Dec. 31, 2011
CURRENT ASSETS:
Cash and equivalents
Total Current Assets
Intellectual Property:
Gift Card Digest Website, net
RxTC Solutions, net	2,500	10,000
Medipayments, net	2,500	10,000
Total Other Assets	5,000	20,000
Total Assets	5,000	20,000
CURRENT LIABILITIES:
Accrued Expenses	3,500	7,250
Advances from Related Parties	9,000	5,700
Total Current Liabilities	12,500	12,950
Total Liabilities	12,500	12,950
Stockholders' equity:
Preferred Stock, par value $.001; 10,000,000 shares authorized; 0 issued and outstanding at September 30, 2012 and December 31, 2011
Common stock, par value $.001; 500,000,000 shares authorized; 94,441,850 shares issued and outstanding at September 30, 2012; 78,121,850 shares issued and outstanding at December 31, 2011	94,442	78,122
Additional paid in capital	144,680	132,600
Deficit accumulated during the development stage	(246,622)	(203,672)
Total Stockholders' Equity	(7,500)	7,050
Total Liabilites and Stockholder's Equity (Deficit)	$ 5,000	$ 20,000